CAMBRIDGE, Mass., Aug. 9, 2011 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI) today highlighted its recent clinical and business progress and announced its second quarter 2011 financial results. During the quarter, the company continued to advance its pipeline of novel drug candidates while maintaining a strong financial profile.
